ES2386282T3 - Método y composición para prevenir o reducir la diarrea - Google Patents
Método y composición para prevenir o reducir la diarrea Download PDFInfo
- Publication number
- ES2386282T3 ES2386282T3 ES04716471T ES04716471T ES2386282T3 ES 2386282 T3 ES2386282 T3 ES 2386282T3 ES 04716471 T ES04716471 T ES 04716471T ES 04716471 T ES04716471 T ES 04716471T ES 2386282 T3 ES2386282 T3 ES 2386282T3
- Authority
- ES
- Spain
- Prior art keywords
- gellan gum
- composition according
- diarrhea
- administered
- diet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims description 35
- 238000000034 method Methods 0.000 title abstract description 3
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 58
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 54
- 239000000216 gellan gum Substances 0.000 claims abstract description 54
- 241000124008 Mammalia Species 0.000 claims abstract description 22
- 235000005911 diet Nutrition 0.000 claims description 28
- 230000037213 diet Effects 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 14
- 241000282326 Felis catus Species 0.000 claims description 12
- 230000037396 body weight Effects 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000306 component Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 5
- 230000001142 anti-diarrhea Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 235000012041 food component Nutrition 0.000 claims description 2
- 239000005428 food component Substances 0.000 claims description 2
- 230000037406 food intake Effects 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 235000011888 snacks Nutrition 0.000 claims description 2
- 235000006180 nutrition needs Nutrition 0.000 claims 1
- 235000013372 meat Nutrition 0.000 description 14
- 235000015067 sauces Nutrition 0.000 description 11
- 238000000151 deposition Methods 0.000 description 9
- 230000008021 deposition Effects 0.000 description 9
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 235000020940 control diet Nutrition 0.000 description 6
- 235000021195 test diet Nutrition 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 4
- 241000282465 Canis Species 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 241000282324 Felis Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000736110 Sphingomonas paucimobilis Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000179442 Anacharis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical group OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010017918 Gastroenteritis viral Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/272—Gellan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US387167 | 2003-03-12 | ||
| US10/387,167 US20040180079A1 (en) | 2003-03-12 | 2003-03-12 | Method and composition |
| PCT/US2004/006358 WO2004080206A1 (en) | 2003-03-12 | 2004-03-02 | Method and composition for preventing or reducing diarrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2386282T3 true ES2386282T3 (es) | 2012-08-16 |
Family
ID=32961840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES04716471T Expired - Lifetime ES2386282T3 (es) | 2003-03-12 | 2004-03-02 | Método y composición para prevenir o reducir la diarrea |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040180079A1 (ja) |
| EP (1) | EP1605776B1 (ja) |
| JP (1) | JP5004580B2 (ja) |
| AT (1) | ATE556602T1 (ja) |
| AU (2) | AU2004220657B2 (ja) |
| BR (1) | BRPI0408213A (ja) |
| CA (1) | CA2518738C (ja) |
| DK (1) | DK1605776T3 (ja) |
| ES (1) | ES2386282T3 (ja) |
| MX (1) | MXPA05009650A (ja) |
| RU (1) | RU2328291C2 (ja) |
| WO (1) | WO2004080206A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8685943B2 (en) * | 2003-03-12 | 2014-04-01 | Hill's Pet Nutrition, Inc. | Methods for reducing diarrhea in a companion animal |
| AU2006304913A1 (en) * | 2005-10-19 | 2007-04-26 | Hill's Pet Nutrition, Inc. | Methods and compositions for improving gastrointestinal health |
| JP4961144B2 (ja) * | 2006-02-07 | 2012-06-27 | 国立医薬品食品衛生研究所長 | 抗ウイルス剤 |
| RU2527290C2 (ru) * | 2009-01-06 | 2014-08-27 | Нестек С.А. | Пищевые композиции в виде ломтиков в желе |
| CN113384736B (zh) * | 2021-06-25 | 2022-10-14 | 东华大学 | 一种普鲁兰-氧化锌杂化纳米纤维/细菌纤维素复合功能性敷料及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS503027B1 (ja) * | 1969-06-12 | 1975-01-30 | ||
| JPS5988051A (ja) * | 1982-11-05 | 1984-05-21 | メルク エンド カムパニー インコーポレーテッド | 食品ゲル系におけるｓ−６０ |
| JPS62130651A (ja) * | 1985-12-03 | 1987-06-12 | San Ei Chem Ind Ltd | 動物用飼料 |
| US5419283A (en) * | 1992-04-08 | 1995-05-30 | Ciuffo Gatto S.R.L. | Animal chew toy of starch material and degradable ethylene copolymer |
| US5339771A (en) * | 1993-09-15 | 1994-08-23 | Axelrod Herbert R | Animal chew toy containing animal meal |
| US5456937A (en) * | 1994-06-24 | 1995-10-10 | Chalupa; William F. | Gellan gum flavor beads |
| US5596084A (en) * | 1994-10-05 | 1997-01-21 | Monsanto Company | Alginate gels |
| JPH09172980A (ja) * | 1995-12-28 | 1997-07-08 | Ajinomoto Co Inc | 新規リン酸アミノ酸複合塩及び水溶性高分子を含有する反すう動物用飼料添加組成物 |
| US5869118A (en) * | 1996-11-13 | 1999-02-09 | Abbott Laboratories | Gellan gum to improve physical stability of liquid nutritional products |
| US5895804A (en) * | 1997-10-27 | 1999-04-20 | National Starch And Chemical Investment Holding Corporation | Thermosetting polysaccharides |
| US6280779B1 (en) * | 1999-12-28 | 2001-08-28 | Colgate-Palmolive Company | Pet food for maintaining normal bowel health |
| GB0203431D0 (en) * | 2002-02-13 | 2002-04-03 | Mars Inc | Gel |
| US6881419B2 (en) * | 2002-04-09 | 2005-04-19 | William E. Lovett | Vitamin formulation for enhancing bone strength |
-
2003
- 2003-03-12 US US10/387,167 patent/US20040180079A1/en not_active Abandoned
-
2004
- 2004-03-02 JP JP2006509003A patent/JP5004580B2/ja not_active Expired - Lifetime
- 2004-03-02 WO PCT/US2004/006358 patent/WO2004080206A1/en active Application Filing
- 2004-03-02 EP EP04716471A patent/EP1605776B1/en not_active Expired - Lifetime
- 2004-03-02 DK DK04716471.0T patent/DK1605776T3/da active
- 2004-03-02 AU AU2004220657A patent/AU2004220657B2/en not_active Ceased
- 2004-03-02 MX MXPA05009650A patent/MXPA05009650A/es active IP Right Grant
- 2004-03-02 BR BRPI0408213-3A patent/BRPI0408213A/pt not_active Application Discontinuation
- 2004-03-02 RU RU2005131583/13A patent/RU2328291C2/ru not_active IP Right Cessation
- 2004-03-02 CA CA2518738A patent/CA2518738C/en not_active Expired - Fee Related
- 2004-03-02 ES ES04716471T patent/ES2386282T3/es not_active Expired - Lifetime
- 2004-03-02 AT AT04716471T patent/ATE556602T1/de active
-
2010
- 2010-10-01 AU AU2010226919A patent/AU2010226919B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20040180079A1 (en) | 2004-09-16 |
| JP5004580B2 (ja) | 2012-08-22 |
| BRPI0408213A (pt) | 2006-02-14 |
| AU2004220657B2 (en) | 2010-07-01 |
| RU2328291C2 (ru) | 2008-07-10 |
| MXPA05009650A (es) | 2005-10-20 |
| RU2005131583A (ru) | 2006-02-10 |
| AU2010226919A1 (en) | 2010-10-28 |
| AU2010226919B2 (en) | 2012-08-30 |
| CA2518738A1 (en) | 2004-09-23 |
| AU2004220657A1 (en) | 2004-09-23 |
| ATE556602T1 (de) | 2012-05-15 |
| EP1605776A1 (en) | 2005-12-21 |
| WO2004080206A1 (en) | 2004-09-23 |
| DK1605776T3 (da) | 2012-08-13 |
| JP2006519863A (ja) | 2006-08-31 |
| EP1605776B1 (en) | 2012-05-09 |
| CA2518738C (en) | 2012-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2258076T3 (es) | Productos de inulina con propiedades nutricionales mejoradas. | |
| JP4838919B2 (ja) | 水生動物の抗ストレス剤 | |
| US9028861B2 (en) | Method and composition to reduce diarrhea in a companion animal | |
| ES2333259T3 (es) | Composiciones destinadas a mejorar la salud intestinal y el rendimiento en animales que comprenden beta-glucanos y alfa-fucanos. | |
| AU2010226919B2 (en) | Method and composition for preventing or reducing diarrhea | |
| CN1668319A (zh) | 整肠性组合物、整肠健康饮料以及大肠内清洗液 | |
| JPH07313071A (ja) | 餌 料 | |
| JP4113242B1 (ja) | 消化器症状の防止剤 | |
| JP2004189685A (ja) | 機能性経口組成物 | |
| US20020016307A1 (en) | Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity | |
| JP3199097U (ja) | 黒酢グルコサミン混合物を含有する錠剤 | |
| JP2007022982A (ja) | 便通改善剤及び便通改善食品 | |
| JP2008169168A (ja) | 骨密度向上剤 | |
| JP2008285431A (ja) | 養殖魚のウイルス感染症の予防・治療組成物 | |
| JP6795662B2 (ja) | ウロプラキン発現促進剤 | |
| Itami | Promising strategies against WSSV for kuruma shrimp in Japan | |
| JP2005312305A (ja) | 健康剤 | |
| JP3193019U (ja) | グルコサミン含有糖衣錠 | |
| TW202412842A (zh) | 口服組成物，及抑制來自麥角硫因之苦味及來自葡萄糖胺類化合物之異味之方法 | |
| US20050202038A1 (en) | Composition and method for minimizing residual fecal matter in the perianal area | |
| Raju et al. | Effect of certain immunomodulatory substances on the growth and disease resistance of Penaeus monodon (Fabricius) | |
| JP2016065005A (ja) | コンドロイチン製剤 | |
| JP2019031443A (ja) | 甲殻類のウイルス抵抗性増進剤及び飼料 | |
| KR20140006004A (ko) | 장 통과 조절 효과를 제공하기 위한 갈락토프룩토오스 |